D. Ayers

Phase I Study of Liposomal Vincristine

Karen A. Gelmon, A. Tolcher, Abdel-Aziz Diab et al. · Journal of Clinical Oncology · 1999 · 111 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase I and Pharmacologic Study of the Human DNA Methyltransferase Antisense Oligodeoxynucleotide MG98 given as a 21-day Continuous Infusion Every 4 Weeks

Alison Davis, Karen A. Gelmon, Lillian L. Siu et al. · Investigational New Drugs · 2003 · 91 citations

Medicine, Pharmacokinetics, Pharmacology +11

Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer.

Karen A. Gelmon, Anthony W. Tolcher, Craig I. Campbell et al. · Journal of Clinical Oncology · 1996 · 60 citations

Medicine, Oncology, Pharmacology +17

A phase I study of AMD473 and docetaxel given once every 3 weeks in patients with advanced refractory cancer: a National Cancer Institute of Canada-Clinical Trials Group trial, IND 131

Karen A. Gelmon, Doug Stewart, K.N. Chi et al. · Annals of Oncology · 2004 · 20 citations

Medicine, Oncology, Pharmacotherapy +7

A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of OGX-011, a 2'methoxyethyl phosphorothioate antisense to <i>clusterin</i>, in patients with prostate cancer prior to radical prostatectomy

K. N., E. Eisenhauer, Ladan Fazli et al. · Journal of Clinical Oncology · 2004 · 15 citations

Medicine, Oncology, Pharmacology +7